Is carotid atherosclerosis more important in patients with mitral annular calcification than in those without?

Basri Amasyali1, Sedat Kose, Kudret Aytemir

  • 1Department of Cardiology, Gulhane Military Medical Academy, Ankara, Turkey.

Japanese Heart Journal
|September 9, 2004
PubMed

Insights

Mitral annular calcification (MAC) and carotid atherosclerosis (CAS) together predict coronary artery disease (CAD) severity. Patients with both MAC and CAS have significantly higher rates of CAD and multivessel disease.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Medical Imaging

Background:

  • Mitral annular calcification (MAC) is potentially linked to generalized atherosclerosis.
  • The combined impact of MAC and carotid atherosclerosis (CAS) on coronary artery disease (CAD) remains unexamined.
  • Understanding this relationship is crucial for assessing cardiovascular risk.

Purpose of the Study:

  • To investigate the clinical impact of coexisting carotid atherosclerosis (CAS) on the frequency and severity of coronary artery disease (CAD) in patients with mitral annular calcification (MAC).
  • To determine if MAC and CAS are independent predictors of CAD.

Main Methods:

  • 101 patients with echocardiographic MAC and 52 controls without MAC were studied.
  • Carotid Doppler ultrasonography was performed before coronary angiography.
  • CAD presence and severity (number of obstructed vessels) were assessed.

Main Results:

  • Patients with both MAC and CAS showed significantly higher incidences of CAD (91% vs. 68%) and multivessel disease (76% vs. 44%) compared to controls with CAS alone.
  • Among patients without CAS, MAC did not significantly increase CAD or multivessel disease rates.
  • CAS, MAC, and hypertension were identified as independent predictors of CAD.

Conclusions:

  • The coexistence of CAS is a critical factor in patients with MAC, indicating a higher likelihood and severity of underlying CAD.
  • In MAC patients without CAS, alternative etiologies beyond atherosclerosis may be involved.
  • Combined assessment of MAC and CAS provides valuable prognostic information for CAD.

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...